| answer text |
<p>Veterinary medicines have been recognised by the Government as critical to human
and animal welfare and national security.</p><p> </p><p>The majority of veterinary
medicines used in the UK (and ingredients and components to make them) are either
produced in or enter via the EU. The Government is working with animal health companies
who have been carrying out extensive EU Exit contingency planning for all EU Exit
scenarios, including no deal, covering all aspects of their supply chains, from regulatory
compliance and stocking levels to logistics and customs. This includes, as appropriate,
increasing stocks of product in the UK, changing supply routes, transferring marketing
authorisations and other regulatory processes.</p><p> </p><p>Additional cross-government
activities include a comprehensive business/trader readiness information campaign
to help individuals and businesses understand what they need to do to get ready for
Brexit and the Government’s Freight Capacity Framework is intended to support the
continued supply of Category 1 goods (to include veterinary medicines) in the event
of border disruption.</p><p> </p><p>Supply is expected to cope with a normalised ordering
pattern.</p><p> </p><p>With this planning in place, we are confident that we have
made every effort to ensure continuity of supply of veterinary medicines in the UK.</p>
|
|
